Ana Camelo, Phd
Research Scientist, Immunology, MedImmune
Dr. Camelo performed her postdoctoral research in Dr. Andrew McKenzie’s lab at the MRC Laboratory of Molecular Biology, where she studied the biology of innate lymphoid cells (ILCs). She then followed her dreams to make a difference in patients’ lives by joining MedImmune, the global biologics research and development arm of AstraZeneca, an innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of small molecule and biologic prescription medicines. Ana continued her interest in ILCs in chronic inflammatory diseases at MedImmune.
LCs in chronic diseases Translational ILC research